Lee DH - Search Results

1

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.

Gainor JF, Curigliano G, Kim DW, Lee DH, Besse B, Baik CS, Doebele RC, Cassier PA, Lopes G, Tan DSW, Garralda E, Paz-Ares LG, Cho BC, Gadgeel SM, Thomas M, Liu SV, Taylor MH, Mansfield AS, Zhu VW, Clifford C, Zhang H, Palmer M, Green J, Turner CD, Subbiah V. Gainor JF, et al. Among authors: lee dh. Lancet Oncol. 2021 Jul;22(7):959-969. doi: 10.1016/S1470-2045(21)00247-3. Epub 2021 Jun 9. Lancet Oncol. 2021. PMID: 34118197 Clinical Trial.

2

Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.

Han JY, Cho KH, Lee DH, Kim HY, Kim EA, Lee SY, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js. J Clin Oncol. 2005 May 20;23(15):3488-94. doi: 10.1200/JCO.2005.01.082. J Clin Oncol. 2005. PMID: 15908658 Clinical Trial.

3

Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.

Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS. Lee DH, et al. Among authors: lee js. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1037-44. doi: 10.1016/j.ijrobp.2005.04.034. Epub 2005 Jul 18. Int J Radiat Oncol Biol Phys. 2005. PMID: 16024178 Clinical Trial.

4

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer.

Han JY, Lee DH, Lee SY, Park CG, Kim HY, Kim EA, Yoon SM, Lee HG, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js, lee hg. Med Oncol. 2005;22(3):281-90. doi: 10.1385/MO:22:3:281. Med Oncol. 2005. PMID: 16110139 Clinical Trial.

5

Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma.

Han JY, Lim HS, Lee DH, Ju SY, Lee SY, Kim HY, Park YH, Park CG, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js. Cancer. 2006 Feb 15;106(4):873-80. doi: 10.1002/cncr.21668. Cancer. 2006. PMID: 16411223 Free article. Clinical Trial.

6

A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer.

Lee DH, Han JY, Yoon SM, Lee JJ, Lee HG, Kim HY, Yoon SJ, Hong EK, Lee JS. Lee DH, et al. Among authors: lee js, lee hg, lee jj. Am J Clin Oncol. 2006 Apr;29(2):143-7. doi: 10.1097/01.coc.0000203743.32845.40. Am J Clin Oncol. 2006. PMID: 16601432 Clinical Trial.

7

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.

Han JY, Lim HS, Shin ES, Yoo YK, Park YH, Lee JE, Jang IJ, Lee DH, Lee JS. Han JY, et al. Among authors: lee dh, lee js, lee je. J Clin Oncol. 2006 May 20;24(15):2237-44. doi: 10.1200/JCO.2005.03.0239. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636344

8

A phase II trial of docetaxel plus capecitabine in patients with previously treated non-small cell lung cancer.

Lee JJ, Han JY, Lee DH, Kim HY, Chun JH, Lee HG, Yoon SM, Lee SY, Lee JS. Lee JJ, et al. Among authors: lee dh, lee sy, lee js, lee hg. Jpn J Clin Oncol. 2006 Dec;36(12):761-7. doi: 10.1093/jjco/hyl106. Epub 2006 Oct 16. Jpn J Clin Oncol. 2006. PMID: 17043059 Clinical Trial.

9

A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer.

Lee DH, Kim SW, Bae KS, Hong JS, Suh C, Kang YK, Lee JS. Lee DH, et al. Among authors: lee js. Clin Cancer Res. 2007 Oct 15;13(20):6182-6. doi: 10.1158/1078-0432.CCR-07-0534. Clin Cancer Res. 2007. PMID: 17947485 Clinical Trial.

10

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.

Han JY, Lee DH, Song JE, Lee SY, Kim HY, Kim HT, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js. Cancer. 2008 Jul 15;113(2):388-95. doi: 10.1002/cncr.23582. Cancer. 2008. PMID: 18484595 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,779 results

Search Page